Erin L. Foster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erin L. Foster has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Ella Jeffreys
Department of Dermatology, Rocky Vista University College of Osteopathic Medicine, Englewood, Colorado
2 shared publications- Jaclyn Roland-McGowan
School of Medicine, Oregon Health & Science University , Portland, OR
2 shared publications Kevin White
Department of Dermatology, Oregon Health and Science University, Portland, OR; and
2 shared publicationsMichi M. Shinohara
Division of Dermatology, University of Washington, Seattle, WA
2 shared publicationsAfsoon Bs Ghafari-Saravi
Department of Dermatology, Oregon Health and Science University, Portland, OR
1 shared publicationAlisa A. Suen-Wallach
University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina
1 shared publication
Latest Publications
- 10 September 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Health domains and outcome measurement instruments in adult vulvovaginal lichen planus studies: a scoping review
This scoping review of 32 studies systematically mapped health domains and measurement instruments used in adult vulvovaginal lichen planus (VVLP) research. Four primary outcome domains were identified: patient-reported symptoms, clinician-assessed signs, quality of life and ‘other’, with substantial heterogeneity in both domain coverage and instrument selection across studies. These findings provide an evidence-based foundation for developing a core outcome set for VVLP.
- 10 September 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Health domains and outcome measurement instruments in adult vulvovaginal lichen planus studies: a scoping review
This scoping review of 32 studies systematically mapped health domains and measurement instruments used in adult vulvovaginal lichen planus (VVLP) research. Four primary outcome domains were identified: patient-reported symptoms, clinician-assessed signs, quality of life and ‘other’, with substantial heterogeneity in both domain coverage and instrument selection across studies. These findings provide an evidence-based foundation for developing a core outcome set for VVLP.
- Open Access
- 26 June 2026
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 12 (2) , e278
Vulvar fixed drug eruption: a rare manifestation of cutaneous adverse drug reaction
- 26 June 2026
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 12 (2) , e278
Open AccessVulvar fixed drug eruption: a rare manifestation of cutaneous adverse drug reaction
- 18 April 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (10)
JAK inhibition in extensive genital and extragenital lichen sclerosus
- 18 April 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (10)
JAK inhibition in extensive genital and extragenital lichen sclerosus
- 9 March 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 121
Evaluation of online patient education materials on oral and genital lichen planus
- 9 March 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 121
Evaluation of online patient education materials on oral and genital lichen planus
- Open Access
- 14 May 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (4) , 719-731
Genital Psoriasis: Shining Light on This Hidden Disease
Background: Psoriasis occurring on the skin of the genital and perigenital regions, including the inguinal creases, vulva, penis, scrotum, perianal area, and the intergluteal cleft, has specific diagnostic and treatment requirements due to the sensitivity and private nature of these areas.Objectives: A multidisciplinary group of 13 US‐based clinicians who are experts in the management of genital psoriasis, the Genital Psoriasis Wellness Consortium, convened to discuss the impact of genital psoriasis on patients focusing on three main domains: (1) physical diagnosis and patient conversations, (2) impact on patient quality of life/interpersonal relationships, and (3) treatment decisions.Methods: A PubMed literature search was conducted, and the Consortium members used the results to formulate their consensus statements using a modified Delphi process, including a nominal group technique. The process included two rounds of virtual subcommittee meetings based on the three domains, followed by surveys to obtain anonymous feedback, and concluded with a final meeting to discuss and finalize the language of the consensus recommendations across all three domains. Three additional psoriasis experts provided feedback on these consensus statements from Canadian, European, and Asian perspectives.Results: Herein, we report our 14 consensus statements and a summary of the supporting data.Conclusions: These consensus statements are meant as a practical resource for clinicians to ensure that symptoms of genital psoriasis are not overlooked. We hope to continue to add to these statements as additional clinical data become available.
- 14 May 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (4) , 719-731
Open AccessGenital Psoriasis: Shining Light on This Hidden Disease
Background: Psoriasis occurring on the skin of the genital and perigenital regions, including the inguinal creases, vulva, penis, scrotum, perianal area, and the intergluteal cleft, has specific diagnostic and treatment requirements due to the sensitivity and private nature of these areas.Objectives: A multidisciplinary group of 13 US‐based clinicians who are experts in the management of genital psoriasis, the Genital Psoriasis Wellness Consortium, convened to discuss the impact of genital psoriasis on patients focusing on three main domains: (1) physical diagnosis and patient conversations, (2) impact on patient quality of life/interpersonal relationships, and (3) treatment decisions.Methods: A PubMed literature search was conducted, and the Consortium members used the results to formulate their consensus statements using a modified Delphi process, including a nominal group technique. The process included two rounds of virtual subcommittee meetings based on the three domains, followed by surveys to obtain anonymous feedback, and concluded with a final meeting to discuss and finalize the language of the consensus recommendations across all three domains. Three additional psoriasis experts provided feedback on these consensus statements from Canadian, European, and Asian perspectives.Results: Herein, we report our 14 consensus statements and a summary of the supporting data.Conclusions: These consensus statements are meant as a practical resource for clinicians to ensure that symptoms of genital psoriasis are not overlooked. We hope to continue to add to these statements as additional clinical data become available.
- Open Access
- 2 May 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 61, 51-54
A case of vulvar cutaneous endometriosis presenting as a chronic, fluctuating labial ulcer in an adolescent female
- 2 May 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 61, 51-54
Open AccessA case of vulvar cutaneous endometriosis presenting as a chronic, fluctuating labial ulcer in an adolescent female
- Open Access
- 6 March 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 47, 10-13
A case of Schnitzler-like syndrome with basement membrane IgM deposition but without monoclonal gammopathy
- 6 March 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 47, 10-13
Open AccessA case of Schnitzler-like syndrome with basement membrane IgM deposition but without monoclonal gammopathy
- 10 January 2024
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 28 (2) , 202-204
Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate
We report the successful treatment of severe vulvar lichen sclerosus refractory to topical corticosteroids in 3 adult female patients using low-dose oral methotrexate. All cases reported symptomatic and clinical improvement within 12 weeks.
- 10 January 2024
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 28 (2) , 202-204
Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate
We report the successful treatment of severe vulvar lichen sclerosus refractory to topical corticosteroids in 3 adult female patients using low-dose oral methotrexate. All cases reported symptomatic and clinical improvement within 12 weeks.
- 1 April 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (4) , 310-311
Solitary Subcutaneous Nodule on the Eyelid: Answer
- 1 April 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (4) , 310-311
Solitary Subcutaneous Nodule on the Eyelid: Answer
- 1 April 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (4) , e44
Solitary Subcutaneous Nodule on the Eyelid: Challenge
- 1 April 2021
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 43 (4) , e44
Solitary Subcutaneous Nodule on the Eyelid: Challenge